Company: Truveta, Bellevue, WA
Company Description: With the availability of daily updated data for nearly 100 million Americans, we’ve been working with contributors and media like yourself to provide timely data for public health conversations. Truveta is a growing collective of more than 30 US health systems that have come together to share their de-identified patient data with the mission of saving lives with data.
Nomination Category: Achievement Categories
Nomination Sub Category: Achievement in Science or Technology
 Nomination Title: AI-enabled health research with Truveta
- If you are providing written answers for your submission, you must provide an answer to this first question: Briefly describe the nominated organization's history and past performance (up to 200 words):
Total 200 words used.
Truveta is using AI to unlock medical insights that will improve healthcare for everyone. Truveta is a growing collective of more than 30 U.S. health systems, who provide 18% of the daily clinical care, with a shared mission of Saving Lives with Data. Trusted by more than 50 leading life science, government, and healthcare organizations, Truveta enables scientifically rigorous research with regulatory-grade data and powerful analytics.
As the COVID-19 pandemic ravaged the world, healthcare providers struggled to learn how to treat the virus – millions died. The world needed faster answers, clearer guidance, and the opportunity to learn from each other. It became clear – the world needed Truveta. In September 2020, the company was founded by innovative health systems pooling their electronic health data for research.
Since its founding, the company has grown from a dozen employees to more than 250 experts in health science and technology and from 14 health systems to more than 30. Pfizer, Boston Scientific, Moderna, Boehringer Ingelheim, UCB, and other life science organizations use Truveta to advance medical research and save lives. And now the CDC will use Truveta Data for ongoing respiratory virus surveillance and to study maternal health and pediatric care.
- Which will you submit for your nomination in this category, a video of up to five (5) minutes in length about the nominated organization's science or technology achievements since the beginning of 2022, OR written answers to the questions? (Choose one):
Written answers to the questions
- If you are submitting a video of up to five (5) minutes in length, provide the URL of the nominated video here, OR attach it to your entry via the "Add Attachments, Videos, or Links to This Entry" link above, through which you may also upload a copy of your video:
- If you are providing written answers for your submission, you must provide an answer to this second question: Outline the organization's achievements since the beginning of 2022 that you wish to bring to the judges' attention (up to 250 words):
Total 244 words used.
In January 2022, Truveta announced a strategic collaboration with Pfizer to deliver new safety insights on a continuous basis, using verifiable real-world data at scale. Simultaneously, Truveta Data grew from 40 million patients to more than 100 million patients in under two years since its founding. Later in 2022, among other accomplishments, the company unveiled Truveta Studio which brings together unprecedented health data and analytics for researchers to study patient care and outcomes with any condition, drug, or medical device.
In 2023, the team continued the innovative momentum with the release of the Truveta Language Model (TLM), a large-language, multi-modal AI model for transforming EHR data into billions of clean and accurate data points for health research on patient outcomes.
TLM’s healthcare expertise is trained on the largest collection of complete medical records representing the full diversity of the U.S. It is the first large-language model specifically designed to empower researchers to study all patient care and outcomes. Utilizing clean, de-identified data from health system members, TLM is trained upon nearly 100 million patient journeys, including 5.5 billion diagnoses, 3.1 billion encounters, and 2.4 billion medication orders.
In the last year, Truveta has earned several peer-reviewed publications, including in JAMA Pediatrics, Vaccine, Frontiers in Public Health, and more. In 2024, Truveta Data was selected to help facilitate the CDC’s COVID response and surveillance efforts as it enables CDC scientists to access representative patient-level data, without delays, for statistically significant populations.
- If you are providing written answers for your submission, you must provide an answer to this third question: Explain why the achievements you have highlighted are unique or significant. If possible compare the achievements to the performance of other players in your industry and/or to the organization's past performance (up to 250 words):
Total 250 words used.
Truveta brought to life a vision where AI is being used to unlock insights to improve patient care in the U.S. in the last three years. But this couldn’t have been possible without the deep relationship with its health system members or even the advancements in cloud and AI technology of the last 5 years. Unlike other competitors in the market, Truveta was formed and founded by health systems.
Truveta is a growing collective of more than 30 health systems who provide over 18% of the daily clinical care across the United States. Member health systems provide complete medical records for more than 100 million patients, which are then linked across health systems and augmented with claims, social drivers of health (SDOH), and mortality data to provide a complete, longitudinal view of patient journeys.
Using Truveta Data, TLM combines pre-trained open large language models with additional training on the most representative clinical data set to achieve over 90 percent accuracy on diagnoses, medications, lab results, clinical observations, and more. With TLM, Truveta’s community of healthcare and life science customers are currently studying concepts previously inaccessible in messy clinician notes but now structured for analytics, such as seizure frequency, changes in treatment regimen, and adverse reactions to medication.
This massive transformation of healthcare data is only possible with state-of-the-art AI. Truveta’s team of technologists and clinical experts have decades of experience in their domains and are leading the industry in using AI to accurately make health data useful for research.
- Optional: Reference here any attachments of supporting materials throughout this nomination and explain how they provide evidence of the claims you have made in this nomination (up to 250 words):
Total 165 words used.
In the attached items, we provided two product press releases/news blogs for more information about Truveta Language Model and Truveta Studio.
We also provided two news-related press releases focused on some of the areas highlighted in the submission around the CDC partnership and our first peer-reviewed research with JAMA Pediatrics.
Finally, we provided a sample of some earned coverage mentions in top-tier outlets focused on our comparative effectiveness research of GLP-1s from last fall.
| Attachments/Videos/Links: |
|---|
|
